Biography

Dr. Yvonne Bombard is a genomics health services researcher and Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Unity Health Toronto. She is a Professor at the Institute of Health Policy, Management and Evaluation at the University of Toronto and directs the Genomics Health Services Research Program at St. Michael’s Hospital. Dr. Bombard holds the Canada Research Chair in Genomics Health Services and Policy. She sets research direction at national and international levels as Board Member of the American Society of Human Genetics and CIHR’s Institute of Genetics. Dr. Bombard advises on funding recommendations on emerging genetic testing technologies for Ontario. Dr. Bombard was the inaugural recipient of the Maurice McGregor Award for Demonstrated Excellence and Leadership Potential from the Canadian Agency for Drugs and Technologies in Health (CADTH) and also received a ‘Rising Star’ award from CIHR’s Institute of Health Services and Policy Research. She has been awarded a CIHR Foundation grant as an Early Career Investigator, CIHR Maud Menten Early Career Prize in Genetics and recently received Canadian Cancer Society’s early career investigator award for her work and policy change.

Recent Publications

  1. Martyn, M, Lee, L, Jan, A, Tytherleigh, R, Lynch, F, Mighton, C et al.. Offering complex genomic screening in acute pediatric settings: family decision-making and outcomes. Genet Med. 2024; :101327. doi: 10.1016/j.gim.2024.101327. PubMed PMID:39548854 .
  2. Mighton, C, Kodida, R, Shickh, S, Clausen, M, Reble, E, Sam, J et al.. Opportunistic genomic screening has clinical utility: An interventional cohort study. Genet Med. 2024; :101323. doi: 10.1016/j.gim.2024.101323. PubMed PMID:39530317 .
  3. Goh, ES, Chad, L, Richer, J, Bombard, Y, Mighton, C, Agatep, R et al.. Canadian College of Medical Geneticists: clinical practice advisory document - responsibility to recontact for reinterpretation of clinical genetic testing. J Med Genet. 2024; :. doi: 10.1136/jmg-2024-110330. PubMed PMID:39362754 .
  4. Uberoi, D, Dalpé, G, Cheung, K, Kondrup, E, Palmour, N, Arawi, T et al.. The Key Features of a Genetic Nondiscrimination Policy: A Delphi Consensus Statement. JAMA Netw Open. 2024;7 (9):e2435355. doi: 10.1001/jamanetworkopen.2024.35355. PubMed PMID:39325459 .
  5. Casalino, S, Mighton, C, Clausen, M, Frangione, E, Aujla, N, MacDonald, G et al.. A Genomic Counseling Model for Population-Based Sequencing: A Pre-Post Intervention Study. Genet Med. 2024;26 (12):101272. doi: 10.1016/j.gim.2024.101272. PubMed PMID:39301805 .
  6. Majeed, S, Johnston, C, Saeedi, S, Mighton, C, Rokoszak, V, Abbasi, I et al.. International policies guiding the selection, analysis, and clinical management of secondary findings from genomic sequencing: A systematic review. Am J Hum Genet. 2024;111 (10):2079-2093. doi: 10.1016/j.ajhg.2024.08.012. PubMed PMID:39299240 PubMed Central PMC11480791.
  7. Raven-Adams, MC, Hernandez-Boussard, T, Joly, Y, Knoppers, BM, Chandrasekharan, S, Thorogood, A et al.. Defining and pursuing diversity in human genetic studies. Nat Genet. 2024;56 (10):1985-1988. doi: 10.1038/s41588-024-01903-7. PubMed PMID:39251787 .
  8. D'Amours, G, Clausen, M, Luca, S, Reble, E, Kodida, R, Assamad, D et al.. Genetics Navigator: protocol for a mixed methods randomized controlled trial evaluating a digital platform to deliver genomic services in Canadian pediatric and adult populations. BMJ Open. 2024;14 (9):e090084. doi: 10.1136/bmjopen-2024-090084. PubMed PMID:39231549 PubMed Central PMC11407190.
  9. Pollard, S, Ehman, M, Hermansen, A, Weymann, D, Krebs, E, Ho, C et al.. "I Just Assumed This Was Already Being Done": Canadian Patient Preferences for Enhanced Data Sharing for Precision Oncology. JCO Precis Oncol. 2024;8 :e2400184. doi: 10.1200/PO.24.00184. PubMed PMID:39116357 PubMed Central PMC11371116.
  10. Kaiser, B, Uberoi, D, Raven-Adams, MC, Cheung, K, Bruns, A, Chandrasekharan, S et al.. A proposal for an inclusive working definition of genetic discrimination to promote a more coherent debate. Nat Genet. 2024;56 (7):1339-1345. doi: 10.1038/s41588-024-01786-8. PubMed PMID:38914718 .
Search PubMed

Affiliations & Other Activities

  • Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
  • Member, Board of Directors, American Society of Human Genetics
  • Member, CIHR Institute of Genetics Advisory Board
  • Member, Ontario Genetics Advisory Committee, Health Quality Ontario
  • Member, Board of Directors, Exactis Innovation
  • Associate, Ontario Institute of Cancer Research
  • Co-lead, Societal Values and Patient Engagement Program, the Canadian Centre for Applied Research in Cancer Control
  • Member, Provincial Council for Maternal and Child Health’s Prenatal Screening Advisory Committee
  • Member, Steering Committee of the Canadian Coalition for Genetic Fairness